Breaking News Instant updates and real-time market news.

ZS

Zscaler

$47.35

-0.87 (-1.80%)

04:55
10/11/19
10/11
04:55
10/11/19
04:55

Zscaler management to meet with Wedbush

Meeting to be held in San Francisco on October 11 hosted by Wedbush.

  • 11

    Oct

  • 15

    Oct

  • 16

    Dec

ZS Zscaler
$47.35

-0.87 (-1.80%)

09/11/19
FBCO
09/11/19
NO CHANGE
Target $70
FBCO
Outperform
Zscaler price target lowered to $70 from $78 at Credit Suisse
Credit Suisse analyst Brad Zelnick lowered his price target for Zscaler to $70 from $78, while reiterating an Outperform rating on the shares. The analyst notes that the company reported "fairly strong" Q4 results, though the magnitude of the revenue beat was not as robust as previous quarters. Zelnick remains confident in Zscaler as a long-term winner in cloud-delivered security and network transformation, and believes a pullback in the shares presents opportunity.
09/24/19
BREN
09/24/19
UPGRADE
Target $60
BREN
Buy
Zscaler upgraded to Buy from Hold at Berenberg
Berenberg anlayst Joshua Tilton upgraded Zscaler (ZS) to Buy from Hold while lowering his price target for the shares to $60 from $78. After surviving 30 Zscaler current and future customers at last week's user conference, the analyst believes the Palo Alto Networks (PANW) competition concern "is noise." Customer feedback points to continued sustained growth for Zscaler as the company has "superior technology relative to legacy competition," Tilton tells investors in a research note. Following the recent pullback in the shares, the analyst has increased confidence in the sustainability of the multiple.
10/02/19
RHCO
10/02/19
INITIATION
RHCO
Buy
Zscaler initiated with a Buy at SunTrust
SunTrust analyst Joel Fishbein initiated Zscaler with a Buy rating and $73 price target.
10/02/19
RHCO
10/02/19
INITIATION
RHCO
SunTrust initiates infrastructure and security sector
SunTrust analyst Joel Fishbein initiated fourteen stocks in the infrastructure and security sector. Regarding infrastructure, he said he believes "we are in the 3rd inning of a multi year (even multi-decade) opportunity" and projected on-demand penetration of 70% by 2028, adding that "spending on cloud software is projected to grow at ~3x the overall software market rate, resulting in a greater than $208B market opportunity through 2025." However, Fishbein cautioned to "stay selective" as while he is bullish on the underlying trends, "too many investors are chasing too few stories." For cybersecurity, Fishbein noted that it remains a top priority for the corporations, and cited the IDC stating that "worldwide spending on security-related hardware, software, and services is forecast to reach $133.7B in 2022 at a compound annual growth rate of 9.9%." He believes that emerging vendors with innovative technology are growing much faster, and sees a "shift in spending from legacy security providers to next generation technology providers and multi-product platforms." The analyst started eight names with Buy ratings -- Atlassian (TEAM), New Relic (NEWR), ServiceNow (NOW), Splunk (SPLK), Palo Alto Networks (PANW), Rapid7 (RPD), SailPoint (SAIL), and Zscaler (ZS). The other six names Fishbein started with Hold ratings -- PagerDuty (PD), Check Point (CHKP), FireEye (FEYE), Proofpoint (PFPT), Qualys (QLYS), and Tenable Holdings (TENB).

TODAY'S FREE FLY STORIES

MIK

Michaels

$9.86

0.22 (2.28%)

07:57
10/22/19
10/22
07:57
10/22/19
07:57
Hot Stocks
Michaels appoints Mark Cosby as CEO »

Michaels announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$0.74

-0.0948 (-11.42%)

07:57
10/22/19
10/22
07:57
10/22/19
07:57
Downgrade
Pareteum rating change  »

Pareteum downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HAL

Halliburton

$19.60

1.16 (6.29%)

07:56
10/22/19
10/22
07:56
10/22/19
07:56
Recommendations
Halliburton analyst commentary  »

Halliburton guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$19.60

1.16 (6.29%)

07:55
10/22/19
10/22
07:55
10/22/19
07:55
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
U.S. chain store sales rebounded 3.1% in the October 19 week »

U.S. chain store sales…

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

FBP

First BanCorp

$10.24

-0.015 (-0.15%)

07:54
10/22/19
10/22
07:54
10/22/19
07:54
Earnings
First BanCorp reports Q3 EPS 21c, consensus 19c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:53
10/22/19
10/22
07:53
10/22/19
07:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

LNXSF

Lanxess

$0.00

(0.00%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Downgrade
Lanxess rating change  »

Lanxess downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNW

Genworth

$4.31

0.01 (0.23%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Hot Stocks
Genworth receives feedback from Canadian regulators regarding transaction »

Genworth Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

TREE

LendingTree

$317.86

3.4 (1.08%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

  • 19

    Nov

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

, EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Hot Stocks
EQT Midstream Partners-owned MVP says project work will be 90% complete by 2020 »

Mountain Valley announced…

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 05

    Nov

SNN

Smith & Nephew

$43.65

-4.165 (-8.71%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
Smith & Nephew analyst commentary  »

Smith & Nephew CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$146.64

0.5 (0.34%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Initiation
Vulcan Materials initiated  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BBIO

BridgeBio

$18.54

0.29 (1.59%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Hot Stocks
BridgeBio announces presentation of data from subsidiaries studies »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$93.74

0.885 (0.95%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Initiation
TE Connectivity initiated  »

TE Connectivity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

MBRX

Moleculin Biotech

$1.07

-0.005 (-0.47%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Hot Stocks
Moleculin Biotech raises Annamycin production »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Earnings
Breaking Earnings news story on NextEra Energy Partners »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 04

    Dec

AX

Axos Financial

$29.97

0.54 (1.83%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Hot Stocks
Newbridge Securities enters five-year clearing agreement with Axos Clearing »

Newbridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 06

    Nov

  • 04

    Dec

  • 05

    Dec

CVA

Covanta

$17.06

0.31 (1.85%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Downgrade
Covanta rating change  »

Covanta double downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

APH

Amphenol

$100.40

1.35 (1.36%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Initiation
Amphenol initiated  »

Amphenol initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

MAIN

Main Street

$42.50

0.23 (0.54%)

07:41
10/22/19
10/22
07:41
10/22/19
07:41
Downgrade
Main Street rating change  »

Main Street downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

, OPK

Opko Health

$2.12

0.03 (1.44%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Recommendations
Ascendis Pharma, Opko Health, Pfizer analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

OPK

Opko Health

$2.12

0.03 (1.44%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Hot Stocks
Callon Petroleum files presentation highlighting benefits of Carrizo deal »

Callon Petroleum Company…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

BAND

Bandwidth

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Bandwidth rating change  »

Bandwidth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.